Cargando…

Design and Characterization of SGK3-PROTAC1, an Isoform Specific SGK3 Kinase PROTAC Degrader

[Image: see text] SGK3 is a PX domain containing protein kinase activated at endosomes downstream of class 1 and 3 PI3K family members by growth factors and oncogenic mutations. SGK3 plays a key role in mediating resistance of breast cancer cells to class 1 PI3K or Akt inhibitors, by substituting fo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tovell, Hannah, Testa, Andrea, Zhou, Houjiang, Shpiro, Natalia, Crafter, Claire, Ciulli, Alessio, Alessi, Dario R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2019
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6757289/ https://www.ncbi.nlm.nih.gov/pubmed/31461270 http://dx.doi.org/10.1021/acschembio.9b00505

Ejemplares similares

Rapid and Reversible Knockdown of Endogenously Tagged Endosomal Proteins via an Optimized HaloPROTAC Degrader
por: Tovell, Hannah, et al.
Publicado: (2019)

The hVps34‐SGK3 pathway alleviates sustained PI3K/Akt inhibition by stimulating mTORC1 and tumour growth
por: Bago, Ruzica, et al.
Publicado: (2016)

Mechanism of activation of SGK3 by growth factors via the Class 1 and Class 3 PI3Ks
por: Malik, Nazma, et al.
Publicado: (2018)

Homo-PROTACs: bivalent small-molecule dimerizers of the VHL E3 ubiquitin ligase to induce self-degradation
por: Maniaci, Chiara, et al.
Publicado: (2017)

Targeting Protein Kinases Degradation by PROTACs
por: Yu, Fei, et al.
Publicado: (2021)

Structure‐Based Design of a Macrocyclic PROTAC
por: Testa, Andrea, et al.
Publicado: (2019)

Discovery of XL01126: A Potent, Fast, Cooperative, Selective, Orally Bioavailable, and Blood–Brain Barrier Penetrant PROTAC Degrader of Leucine-Rich Repeat Kinase 2
por: Liu, Xingui, et al.
Publicado: (2022)

Structural basis of PROTAC cooperative recognition for selective protein degradation
por: Gadd, Morgan S., et al.
Publicado: (2017)

Non-small molecule PROTACs (NSM-PROTACs): Protein degradation kaleidoscope
por: Ma, Sinan, et al.
Publicado: (2022)

PROTAC-DB: an online database of PROTACs
por: Weng, Gaoqi, et al.
Publicado: (2020)

DeepPROTACs is a deep learning-based targeted degradation predictor for PROTACs
por: Li, Fenglei, et al.
Publicado: (2022)

Characterization of VPS34-IN1, a selective inhibitor of Vps34, reveals that the phosphatidylinositol 3-phosphate-binding SGK3 protein kinase is a downstream target of class III phosphoinositide 3-kinase
por: Bago, Ruzica, et al.
Publicado: (2014)

Trivalent PROTACs enhance protein degradation via combined avidity and cooperativity
por: Imaide, Satomi, et al.
Publicado: (2021)

Development of BromoTag: A “Bump-and-Hole”–PROTAC System to Induce Potent, Rapid, and Selective Degradation of Tagged Target Proteins
por: Bond, Adam G., et al.
Publicado: (2021)

Estrogen Receptor-α Targeting: PROTACs, SNIPERs, Peptide-PROTACs, Antibody Conjugated PROTACs and SNIPERs
por: Negi, Arvind, et al.
Publicado: (2022)

PROTAC-DB 2.0: an updated database of PROTACs
por: Weng, Gaoqi, et al.
Publicado: (2022)

Degradation of proteins by PROTACs and other strategies
por: Wang, Yang, et al.
Publicado: (2020)

Cereblon versus VHL: Hijacking E3 ligases against each other using PROTACs
por: Girardini, Miriam, et al.
Publicado: (2019)

Light-mediated multi-target protein degradation using arylazopyrazole photoswitchable PROTACs (AP-PROTACs)
por: Zhang, Qisi, et al.
Publicado: (2022)

Discovery of small molecule ligands for the von Hippel-Lindau (VHL) E3 ligase and their use as inhibitors and PROTAC degraders
por: Diehl, Claudia J., et al.
Publicado: (2022)

SPR-Measured Dissociation Kinetics of PROTAC Ternary Complexes Influence Target Degradation Rate
por: Roy, Michael J., et al.
Publicado: (2019)

Elevated SGK1 predicts resistance of breast cancer cells to Akt inhibitors
por: Sommer, Eeva M., et al.
Publicado: (2013)

Tubulin Resists Degradation by Cereblon-Recruiting PROTACs
por: Gasic, Ivana, et al.
Publicado: (2020)

RNA‐PROTACs: Degraders of RNA‐Binding Proteins
por: Ghidini, Alice, et al.
Publicado: (2020)

PROTAC targeted protein degraders: the past is prologue
por: Békés, Miklós, et al.
Publicado: (2022)

Mutant-selective degradation by BRAF-targeting PROTACs
por: Alabi, Shanique, et al.
Publicado: (2021)

Contributions of SGK3 to transporter-related diseases
por: Liao, Qian-Qian, et al.
Publicado: (2022)

Proteasomal Degradation of Zn-Dependent Hdacs: The E3-Ligases Implicated and the Designed Protacs That Enable Degradation
por: Márquez-Cantudo, Laura, et al.
Publicado: (2021)

Understanding and Improving the Membrane Permeability of VH032-Based PROTACs
por: Klein, Victoria G., et al.
Publicado: (2020)

E3 Ligase Ligands for PROTACs: How They Were Found and How to Discover New Ones
por: Ishida, Tasuku, et al.
Publicado: (2020)

PROTACs in gastrointestinal cancers
por: Chen, Yu, et al.
Publicado: (2022)

Design, synthesis, and biological evaluation of potent FAK-degrading PROTACs
por: Qin, Qiaohua, et al.
Publicado: (2022)

Degrading AR-Dependent Cancers: Expanding the Role of PROTACs
por: Michmerhuizen, Anna R., et al.
Publicado: (2020)

Light-Controllable PROTACs for Temporospatial Control of Protein Degradation
por: Liu, Jing, et al.
Publicado: (2021)

BacPROTACs mediate targeted protein degradation in bacteria
por: Morreale, Francesca E., et al.
Publicado: (2022)

Recent Advances of Degradation Technologies Based on PROTAC Mechanism
por: Xiao, Mingchao, et al.
Publicado: (2022)

In vitro reconstitution of Sgk3 activation by phosphatidylinositol 3-phosphate
por: Pokorny, Daniel, et al.
Publicado: (2021)

Clinical considerations for the design of PROTACs in cancer
por: Nieto-Jiménez, Cristina, et al.
Publicado: (2022)

Are we ready to design oral PROTACs®?
por: Jimenez, Diego Garcia, et al.
Publicado: (2021)

Lethality of PAK3 and SGK2 shRNAs to Human Papillomavirus Positive Cervical Cancer Cells Is Independent of PAK3 and SGK2 Knockdown
por: Zhou, Nannan, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_1p3m2bpep517kt3qptj6h0hiv2